Review article: immune checkpoint inhibitors and the liver, from therapeutic efficacy to side effects-Reference-Cited by-同舟云学术

Review article: immune checkpoint inhibitors and the liver, from therapeutic efficacy to side effects

Published:2019-08-04 Issue:8 Volume:50 Page:872-884
ISSN:0269-2813
Container-title:Alimentary Pharmacology & Therapeutics
language:en
Short-container-title:Aliment Pharmacol Ther

Author:

Lombardi Andrea¹²^ORCID,Mondelli Mario U.¹²^ORCID

Affiliation:

1. Division of Infectious Diseases II and Immunology, Department of Medical Sciences and Infectious Diseases; Fondazione IRCCS Policlinico San Matteo; Pavia Italy

2. Department of Internal Medicine and Therapeutics; University of Pavia; Pavia Italy

Publisher

Wiley

Subject

Pharmacology (medical),Gastroenterology,Hepatology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/apt.15449/fullpdf

Reference75 articles.

1. Cancer immunotherapy comes of age;Mellman;Nature,2014

2. Immune checkpoint inhibition in hepatocellular carcinoma: basics and ongoing clinical trials;Kudo;Oncology,2017

3. Lenvatinib plus checkpoint inhibitors in patients (pts) with advanced intrahepatic cholangiocarcinoma (ICC): Preliminary data and correlation with next- generation sequencing;Lin;J Clin Oncol,2018

4. HBV and the immune response;Ferrari;Liver Int,2015

Cited by 27 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comprehensive assessment of regulatory T-cells-related scoring system for predicting the prognosis, immune microenvironment and therapeutic response in hepatocellular carcinoma;Aging;2024-03-08

2. Identification and validation of a cancer-associated fibroblasts-related scoring system to predict prognosis and immune landscape in hepatocellular carcinoma through integrated analysis of single-cell and bulk RNA-sequencing;Aging;2023-10-18

3. Immune checkpoint inhibition mediated with liposomal nanomedicine for cancer therapy;Military Medical Research;2023-04-28

4. AASLD practice guidance on drug, herbal, and dietary supplement–induced liver injury;Hepatology;2023-02-17

5. The Current status of steroid-refractory immune-checkpoint-inhibitor-related hepatotoxicity;Translational Oncology;2023-02